Calcitonin systemic is used in the treatment of: 1  Hypercalcemia. 2  Osteogenesis Imperfecta. 3  Osteoporosis. Paget's Disease.
Sources: Fawcett (2006) and Powers (2011). The evaluation of binary classifiers compares two methods of assigning a binary attribute, one of which is usually a standard method and the other is being investigated.
Type III binary compounds contain no metal atoms. There are two different naming systems for Type III binary compounds: the old system and the new system. The old system uses prefixes to indicate the number of each atom present and the new system is identical to that used for naming Type II compounds.